Gamma Investing LLC Verona Pharma PLC Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Gamma Investing LLC holds 116,631 shares of VRNA stock, worth $6.87 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
116,631
Previous 1,612
7135.17%
Holding current value
$6.87 Million
Previous $74.9 Million
97.55%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
226Shares Held
67.7MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$377 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$329 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$199 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$185 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$184 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.59B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...